Page 13 of 19 · 454 questions tagged vendor-vetting.
Conditions: VendorInvestigate · Wuhan Wansheng Biotechnology. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The particulars: purity figure · WWB. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
The specifics, since they change the answer: 97.1% · ecnoglutide · SGN. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
Conditions: lot-specific certificate · SGN. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
What I am working with: 96.4% · mazdutide · QST. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
Details up front: CPC · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Details up front: FGP · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
I would rather spend on verification than on volume. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
I am comparing three suppliers on documentation rather than on price. Everything I have found on this is either a forum aside or a product page, neither of which I…
The case in front of me: sampling plan · QSC. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The specifics, since they change the answer: 96.8% · semaglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
The case in front of me: chromatogram · GGPeps. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want to know whether this is a real physical effect or an artefact of…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Details up front: QST · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
This is my second independent submission on material from the same supplier. I understand the observation; what I do not understand is the mechanism behind it. I have…
The case in front of me: purity figure · KP. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Numbers first: 97.9% · dulaglutide · GL Biochem. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Numbers first: 95.2% · orforglipron · SSA. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Details up front: 97.6% · orforglipron · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Setup, so nobody has to ask: sampling plan · ERP. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
The specifics, since they change the answer: batch certificate · QSC. This is presented as though it settles something, and I am not convinced it does. I have two…
The particulars: 98.4% · ecnoglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
I have both a purity figure and a content figure, which is why the discrepancy is visible. An unexpected observation, and I would like a differential rather than…